The Changes and Clinical Implications of Plasma Urotensin Ⅱ and Adrenomedullin in Patients with Acute Exacerbated Chronic Obstructive Pulmonary Disease Combined with Chronic Heart Failure

XIA Yu,WANG Ping,ZHENG Bi-wei
DOI: https://doi.org/10.3969/j.issn.2095-140x.2011.06.006
2011-01-01
Abstract:Objective To observe the changes of plasma urotensinⅡ(UⅡ) and adrenomedullin(ADM) in patients with acute exacerbated chronic obstructive pulmonary disease(AECOPD) combined with chronic heart failure(CHF) and to discuss their clinical implications.Methods 86 cases with AECOPD were divided into two groups: the heart failure group(n=38) combined with CHF and the non-heart failure group(n=48) not combined CHF.Plasma UⅡ,ADM levels and the left ventricular ejection fraction(LVEF),left ventricular mass index(LVMI) both before and after treatment were measured and analyzed.Results Plasma ADM and UⅡ in heart failure group were significantly higher than that of non-heart failure group before treatment,and they decreased significantly after treatment,but there was still statistical significance compared with that of the non-heart failure group after treatment(P<0.01,P<0.05);there was also statistical significance in the difference of LVEF and LVMI in the heart failure group before treatment compared with that of non-heart failure group,LVEF in heart failure group was significantly increased after treatment,but was still much lower than that of the non-heart failure group(P<0.01,P<0.05);The plasma UⅡ was positively correlated with LVMI and ADM and negatively correlated with LVEF(P<0.01).Conclusion There is good clinical value of Plasma UⅡ and ADM concentrations in identifying whether AECOPD is combined with CHF or not.
What problem does this paper attempt to address?